Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures is a research paper published in Journal of Alzheimer s Disease Reports (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01AG059008-01
Assessment of lenalidomide to treat Alzheimer's disease
National Institutes of Health
Grant: 5P30AG072980-02
Arizona Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1R01AG073212-01
Repurposing Siponimod for Alzheimer's Disease
NIA NIH HHS
Grant: R01 AG059008
NIA NIH HHS
Grant: R01 AG073212
FWCI
0.55
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals